Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene.
暂无分享,去创建一个
M. Araúzo-Bravo | J. Kulisevsky | R. Moratalla | M. Orera | Eva Rodríguez-Traver | C. Vicario | Eva Díaz-Guerra | C. Rodríguez | F. Arenas
[1] R. Moratalla,et al. Cholesterol and multilamellar bodies: Lysosomal dysfunction in GBA-Parkinson disease , 2018, Autophagy.
[2] M. Araúzo-Bravo,et al. A Global Transcriptome Analysis Reveals Molecular Hallmarks of Neural Stem Cell Death, Survival, and Differentiation in Response to Partial FGF-2 and EGF Deprivation , 2013, PloS one.
[3] R. Moratalla,et al. Nurr1 blocks the mitogenic effect of FGF‐2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic‐GABAergic neuronal phenotypes , 2015, Developmental Neurobiology.
[4] J. Kulisevsky,et al. N370S‐GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[5] A. Schapira,et al. The relationship between glucocerebrosidase mutations and Parkinson disease , 2016, Journal of neurochemistry.
[6] J. Hardy,et al. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course , 2012, Movement disorders : official journal of the Movement Disorder Society.